Belo Sun Receives Construction Licence for the Volta Grande Gold Project

Go back to Belo Sun Receives Construction Licence for the Volta Grande Gold Project

Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q

February 3, 2017 9:47 AM EST

Oppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following the company's 4Q report.

Analyst Steven Lichtman commented, "BSX delivered strong, broad-based sales growth in 4Q16 and continued solid operating margin expansion. Sales in the quarter... More